{{NoteTA|G1=ME}}
{{Infobox medical condition (new)
| name            = 卡斯爾曼氏病
| synonyms        = 巨淋巴結增生（Giant lymph node hyperplasia）、類淋巴性錯構瘤（lymphoid hamartoma）、血管濾泡性淋巴結增生（angiofollicular lymph node hyperplasia）、血管瘤性類淋巴缺陷瘤（angiomatous lymphoid hamartoma）
| image           = Castleman disease - high mag.jpg
| caption         = 卡斯爾曼氏病患者的淋巴病理切片，圖中可以看到萎縮的生發中心（germinal center）及增厚的被套區（mantle zone）。圖中貫穿生發中心且細胞較少的粉紅透明構造為硬化的血管，此病理特徵稱為「棒棒糖徵象」（"lollipop" sign），[[苏木精-伊红染色|H&E染色]]。
| pronounce       =
| field           =
| symptoms        =
| complications   =
| onset           =
| duration        =
| types           =
| causes          =
| risks           =
| diagnosis       =
| differential    =
| prevention      =
| treatment       =
| medication      =
| prognosis       =
| frequency       =
| deaths          =
|alt=
}}

'''卡斯爾曼氏病'''（Castleman disease）是一類罕見的{{tsl|en|lymphoproliferative disorder|淋巴增生性疾患}}，疾病特徵主要為[[淋巴結腫大|淋巴結腫大]]。

卡斯爾曼氏病目前已知至少有三種亞型：{{tsl|en|Unicentric Castleman disease|局灶性卡斯爾曼氏病}}（Unicentric Castleman disease，UCD）、{{tsl|en|HHV-8-associated MCD|HHV-8相關性卡斯爾曼氏病|人類疱疹病毒第8型關聯性多發性卡斯爾曼氏病}}（HHV-8-associated MCD），以及{{tsl|en|Idiopathic multicentric Castleman disease|特發性多發性卡斯爾曼氏病}}（idiopathic multicentric Castleman disease，iMCD）。診斷上必須檢視病變淋巴結的位置及數量，以及確認是否有遭到[[人類疱疹病毒第8型|HHV-8]]感染。由於各亞型的症狀、機轉、治療，及預後都不同，因此分型的工作相當重要。在美國，每年新發個案數約為6,500至7,700例左右<ref name=":8">{{Cite journal|last1=Yu|first1=Li|last2=Tu|first2=Meifeng|last3=Cortes|first3=Jorge|last4=Xu-Monette|first4=Zijun Y.|last5=Miranda|first5=Roberto N.|last6=Zhang|first6=Jun|last7=Orlowski|first7=Robert Z.|last8=Neelapu|first8=Sattva|last9=Boddu|first9=Prajwal C.|last10=Akosile|first10=Mary A.|last11=Uldrick|first11=Thomas S.|date=2017-03-23|title=Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease|journal=Blood|language=|volume=129|issue=12|pages=1658–1668|doi=10.1182/blood-2016-11-748855|pmid=28100459|pmc=5364343|issn=0006-4971|doi-access=free}}</ref>。

1956年，{{tsl|en|Benjamin Castleman|班傑明‧卡斯爾曼|班傑明‧卡斯爾曼}}首次描述了此疾病，而此病也因此以他為名。卡斯爾曼氏病合作網路（ The Castleman Disease Collaborative Network）是目前該疾病規模最大的相關團體，致力推動該疾病的研究、推廣，以及提供病友支持<ref>{{Cite web|url=https://cdcn.org/|title=Castleman Disease Collaborative Network|website=CDCN|language=|access-date=2019-12-30|archive-date=2021-02-02|archive-url=https://web.archive.org/web/20210202172706/https://cdcn.org/|dead-url=no}}</ref>。

== 分類 ==
卡斯爾曼氏病目前已知至少有三種亞型：{{tsl|en|Unicentric Castleman disease|局灶性卡斯爾曼氏病}}（Unicentric Castleman disease，UCD）、{{tsl|en|HHV-8-associated MCD|HHV-8相關性卡斯爾曼氏病|人類疱疹病毒第8型關聯性多發性卡斯爾曼氏病}}（HHV-8-associated MCD），以及{{tsl|en|Idiopathic multicentric Castleman disease|特發性多發性卡斯爾曼氏病}}（idiopathic multicentric Castleman disease，iMCD）<ref>{{Cite web|title=What Is Castleman Disease?|url=https://www.cancer.org/cancer/castleman-disease/about/what-is-castleman-disease.html|access-date=2020-10-25|website=www.cancer.org|language=|archive-date=2021-01-15|archive-url=https://web.archive.org/web/20210115173652/https://www.cancer.org/cancer/castleman-disease/about/what-is-castleman-disease.html|dead-url=no}}</ref>。

{{tsl|en|List of lymph nodes of the human body|人類淋巴結列表|淋巴結}}腫大的位置及數量對於卡斯爾曼氏病的分型相當重要<ref name=":4">{{cite journal|authorlink1=David Fajgenbaum | vauthors = Fajgenbaum DC, Shilling D | title = Castleman Disease Pathogenesis | journal = Hematology/Oncology Clinics of North America | volume = 32 | issue = 1 | pages = 11–21 | date = February 2018 | pmid = 29157613 | doi = 10.1016/j.hoc.2017.09.002 }}</ref>。在局灶性卡斯爾曼氏病（UCD）的患者身上，通常僅有一個區域的單顆或數顆淋巴結遭到進犯。多發性卡斯爾曼氏病（MCD）則顧名思義，即[[淋巴結腫大|淋巴結腫大]]的位置散佈於多個區域。在感染症中，目前已知會併發卡斯爾曼氏病的病原體僅有{{tsl|en|Kaposi's sarcoma-associated herpesvirus|人類疱疹病毒第8型|}}（HHV-8）一種<ref name=":4" />。

=== 局灶性卡斯爾曼氏病 ===
局灶性卡斯爾曼氏病（UCD）的患者僅有單一區域的淋巴結受到進犯<ref name=":7">{{Cite journal|last1=Yu|first1=Li|last2=Tu|first2=Meifeng|last3=Cortes|first3=Jorge|last4=Xu-Monette|first4=Zijun Y.|last5=Miranda|first5=Roberto N.|last6=Zhang|first6=Jun|last7=Orlowski|first7=Robert Z.|last8=Neelapu|first8=Sattva|last9=Boddu|first9=Prajwal C.|last10=Akosile|first10=Mary A.|last11=Uldrick|first11=Thomas S.|date=2017-03-23|title=Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease|journal=Blood|language=|volume=129|issue=12|pages=1658–1668|doi=10.1182/blood-2016-11-748855|pmid=28100459|pmc=5364343|issn=0006-4971|doi-access=free}}</ref>。此亞型為最常見的亞型，成因目前尚未闡明。UCD相對另外兩種亞型來說，症狀較為輕微，且通常不會伴隨器官衰竭的情形。治療可透過手術移除病變淋巴結進行，但若患者不適合開刀，則治療比照特發性多發性卡斯爾曼氏病<ref name=":5">{{cite journal | vauthors = Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M, Vercellino L, Meignin V, Gérard L, Galicier L | title = The full spectrum of Castleman disease: 273 patients studied over 20 years | journal = British Journal of Haematology | volume = 180 | issue = 2 | pages = 206–216 | date = January 2018 | pmid = 29143319 | doi = 10.1111/bjh.15019 | doi-access = free }}</ref><ref name=":6">{{cite journal | vauthors = Talat N, Belgaumkar AP, Schulte KM | title = Surgery in Castleman's disease: a systematic review of 404 published cases | url = https://archive.org/details/sim_annals-of-surgery_2012-04_255_4/page/677 | journal = Annals of Surgery | volume = 255 | issue = 4 | pages = 677–84 | date = April 2012 | pmid = 22367441 | doi = 10.1097/SLA.0b013e318249dcdc | s2cid = 7553851 }}</ref>。

=== 特發性多發性卡斯爾曼氏病 ===
特發性多發性卡斯爾曼氏病（iMCD）的患者會有多個區域的淋巴結遭到進犯，且沒有已知病因。該亞型較UCD少見，且症狀較為嚴重。診斷上必須有檢驗報告異常<ref name=":5" />。症狀包含全身性發炎反應及器官衰竭。此類型手術通常無法治癒，需透過藥物治療，治療藥物包含抗病毒藥物、胞毒性化學療法，以及生物製劑等等<ref name=":8" />。

由於iMCD的症狀相對不具特異性，且病因迄今未明，在診斷上相當困難<ref name=":9">{{Cite journal |last1=Iwaki |first1=Noriko |last2=Fajgenbaum |first2=David C. |last3=Nabel |first3=Christopher S. |last4=Gion |first4=Yuka |last5=Kondo |first5=Eisei |last6=Kawano |first6=Mitsuhiro |last7=Masunari |first7=Taro |last8=Yoshida |first8=Isao |last9=Moro |first9=Hiroshi |last10=Nikkuni |first10=Koji |last11=Takai |first11=Kazue |date=2016 |title=Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease |journal=American Journal of Hematology |language= |volume=91 |issue=2 |pages=220–226 |doi=10.1002/ajh.24242 |pmid=26805758 |s2cid=521845 |issn=1096-8652|doi-access=free }}</ref>。

=== 人類疱疹病毒第8型關聯性多發性卡斯爾曼氏病 ===
人類疱疹病毒第8型關聯性多發性卡斯爾曼氏病（HHV-8-associated MCD）是因為HHV-8感染造成的多發性卡斯爾曼氏病，與iMCD一樣也會進犯多處淋巴結，較常發生於有[[人類免疫缺陷病毒|人類免疫缺陷病毒]]（HIV）感染的患者身上。該亞型在臨床症狀和治療上較類似iMCD，通常無法透過手術治癒，需透過藥物治療<ref name=":5" />。

== 相關症候群 ==

=== '''TAFRO症候群''' ===
偶發於某些多發性卡斯爾曼氏病的患者，症狀包含血小板低下、全身性水腫、發燒、網狀纖維化，以及器官腫大。此類患者對於免疫抑制劑及固醇類藥物反應良好<ref>{{Cite journal |last1=Iwaki |first1=Noriko |last2=Fajgenbaum |first2=David C. |last3=Nabel |first3=Christopher S. |last4=Gion |first4=Yuka |last5=Kondo |first5=Eisei |last6=Kawano |first6=Mitsuhiro |last7=Masunari |first7=Taro |last8=Yoshida |first8=Isao |last9=Moro |first9=Hiroshi |last10=Nikkuni |first10=Koji |last11=Takai |first11=Kazue |date=2016 |title=Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease |journal=American Journal of Hematology |language= |volume=91 |issue=2 |pages=220–226 |doi=10.1002/ajh.24242 |pmid=26805758 |s2cid=521845 |issn=1096-8652|doi-access=free }}</ref>。

== 病理學 ==
卡斯爾曼氏病的診斷需透過病變淋巴結的切片進行<ref name=":2">{{cite journal | vauthors = Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS, Casper C, Dispenzieri A, Fosså A, Kelleher D, Kurzrock R, Voorhees P, Dogan A, Yoshizaki K, van Rhee F, Oksenhendler E, Jaffe ES, Elenitoba-Johnson KS, Lim MS | display-authors = 6 | title = International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease | journal = Blood | volume = 129 | issue = 12 | pages = 1646–1657 | date = March 2017 | pmid = 28087540 | pmc = 5364342 | doi = 10.1182/blood-2016-10-746933 }}</ref>，根據組織病理學特徵，可以區分為下列幾個變型（varient）：
* 透明血管型（Hyaline vascular）：[[生發中心|生發中心]]萎縮、{{tsl|en|Follicular dendritic cells|濾泡樹突細胞|}}增生或形態異常、濾泡間區域血管增生、血管硬化。淋巴{{tsl|en|mantle zone|被套區|}}增厚，出現「洋蔥狀」（“onion-skin”）徵象。
* 漿細胞型（Plasmacytic）：[[淋巴結|濾泡]]數量增加及生發中心增生，且片狀（sheet-like）[[浆细胞|漿細胞]]數量增加<ref name=":2" /><ref name=":3">{{cite journal|title=Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations|url=https://archive.org/details/sim_cancer_1972-03_29_3/page/670|date=March 1972|journal=Cancer|issue=3|doi=10.1002/1097-0142(197203)29:3<670::aid-cncr2820290321>3.0.co;2-#|volume=29|pages=670–83|pmid=4551306|vauthors=Keller AR, Hochholzer L, Castleman B}}</ref>。
* 高血管型（Hypervascular）：與透明血管型類似，但此變型主要用於描述iMCD患者的變化。最主要的差異是此亞型的[[淋巴結|淋巴竇]]通常維持通暢，而透明血管型的淋巴竇基本上付之闕如<ref name=":10">{{Cite journal|title=Pathology of Castleman Disease|url=https://www.hemonc.theclinics.com/article/S0889-8588(17)30144-2/abstract|last=Wu|first=David|last2=Lim|first2=Megan S.|date=2018-02-01|journal=Hematology/Oncology Clinics|issue=1|doi=10.1016/j.hoc.2017.09.004|volume=32|pages=37–52|language=|issn=0889-8588|pmid=29157618|last3=Jaffe|first3=Elaine S.}}</ref>。
*混合型（Mixed）：合併有以上三種病理特徵。

在UCD中，大多數患者會以透明血管型表現，僅約一成的患者會以漿細胞型或混和型表現<ref name=":6" /><ref name=":10" />。iMCD則主要以漿細胞型為主，但高血管型、透明血管型及混合型也有機會表現。HHV-8相關卡斯爾曼氏病的病例皆會出現血漿芽細胞性特徵（plasmablastic features），特徵上與漿細胞型類似，但鏡檢下能找到[[血漿芽細胞|血漿芽細胞]]存在<ref name=":2" />。{{tsl|en|LANA|LANA|潛伏期相關核蛋白-1}}（Latency-associated nuclear antigen，LANA-1）是一種HHV-8特有的標記，LANA-1的特殊染色僅會在HHV-8相關卡斯爾曼氏病患者身上顯示陽性<ref name=":1">{{cite journal | vauthors = Liu AY, Nabel CS, Finkelman BS, Ruth JR, Kurzrock R, van Rhee F, Krymskaya VP, Kelleher D, Rubenstein AH, Fajgenbaum DC | title = Idiopathic multicentric Castleman's disease: a systematic literature review | journal = The Lancet. Haematology | volume = 3 | issue = 4 | pages = e163–75 | date = April 2016 | pmid = 27063975 | doi = 10.1016/S2352-3026(16)00006-5 }}</ref>。

由於病理上不同變型之間，無法區分病情嚴重度及預測治療效果，因此目前尚無法藉由組織學特徵進行疾病分型<ref name=":2" />。

== 鑑別診斷 ==
除了卡斯爾曼氏病之外，也有一些疾病也會出現淋巴結腫大的情形，且組織學上也會呈現類似特徵，因此必須對以下疾病進行鑑別診斷<ref name=":2" /><ref name=":10" />：

* 感染病：[[人類疱疹病毒第四型|EB病毒]]、[[人類免疫缺陷病毒|人類免疫缺陷病毒]]（HIV）、[[结核病|分枝桿菌]]（如[[結核桿菌|結核桿菌]]）
* 自體免疫疾病：[[全身性紅斑狼瘡|全身性紅斑狼瘡]]、[[類風濕性關節炎|類風濕性關節炎]]、[[IgG4相关性疾病|IgG4相關性疾病]]、{{tsl|en|Hemophagocytic lymphohistiocytosis|噬血球性淋巴組織球增生症}}、[[成人史迪爾氏病|成人史迪爾氏病]]（AOSD）、{{tsl|en|Autoimmune lymphoproliferative syndrome|自體免疫淋巴增生症候群}}
* 血液腫瘤：[[淋巴瘤|淋巴瘤]]、{{tsl|en|Follicular dendritic cell sarcoma|濾泡樹突細胞肉瘤}}

== 歷史 ==
1956年7月，美國病理學家{{tsl|en|Benjamin Castleman|班傑明‧卡斯爾曼|班傑明‧卡斯爾曼}}（Benjamin Castleman）首次描述了局灶性卡斯爾曼氏病的病例<ref name=":0">{{Cite journal|last1=Castleman|first1=B.|last2=Iverson|first2=L.|last3=Menendez|first3=V. P.|date=July 1956|title=Localized mediastinal lymphnode hyperplasia resembling thymoma|journal=Cancer|volume=9|issue=4|pages=822–830|issn=0008-543X|pmid=13356266|doi=10.1002/1097-0142(195607/08)9:4<822::aid-cncr2820090430>3.0.co;2-4|doi-access=free}}</ref>。到了1984年，開始有一些病例報告描述多發性卡斯爾曼氏病，以及其與[[卡波西氏肉瘤|卡波西氏肉瘤]]之間的關聯<ref>{{cite journal | vauthors = Chen KT | title = Multicentric Castleman's disease and Kaposi's sarcoma | journal = The American Journal of Surgical Pathology | volume = 8 | issue = 4 | pages = 287–93 | date = April 1984 | pmid = 6711739 | doi=10.1097/00000478-198404000-00006| s2cid = 38948699 }}</ref>。到了1995年，學者在[[人類免疫缺陷病毒|HIV]]感染的患者中，發現了HHV-8與卡斯爾曼氏病之間的關聯性<ref>{{cite journal | vauthors = Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L | display-authors = 6 | title = Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | journal = Blood | volume = 86 | issue = 4 | pages = 1276–80 | date = August 1995 | doi = 10.1182/blood.V86.4.1276.bloodjournal8641276 | pmid = 7632932 | doi-access = free }}</ref>。正式的診斷標準則直到2016年才建立，隔年學界首次對iMCD提出國際診斷標準的共識<ref name=":2" />。2018年，針對iMCD的治療指引首次發表<ref>{{Cite journal|last1=van Rhee|first1=Frits|last2=Voorhees|first2=Peter|last3=Dispenzieri|first3=Angela|last4=Fosså|first4=Alexander|last5=Srkalovic|first5=Gordan|last6=Ide|first6=Makoto|last7=Munshi|first7=Nikhil|last8=Schey|first8=Stephen|last9=Streetly|first9=Matthew|date=2018-09-04|title=International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease|journal=Blood|volume=132|issue=20|pages=blood-2018-07-862334|doi=10.1182/blood-2018-07-862334|issn=1528-0020|pmid=30181172|pmc=6238190}}</ref>。

後人於2018年起，將卡斯爾曼發表首篇病例報告的7月23日，訂定為世界卡斯爾曼氏病日（World Castleman Disease Day）<ref name=":0" />。

==文化==
2012年，{{tsl|en|Castleman Disease Collaborative Network|卡斯爾曼氏病合作網路|}}正式建立，為世界上最大的卡斯爾曼病專題組織<ref>{{Cite web|url=https://cdcn.org/|title=Castleman Disease Collaborative Network|publisher=CDCN|language=|access-date=2019-12-30|archive-date=2021-02-02|archive-url=https://web.archive.org/web/20210202172706/https://cdcn.org/|dead-url=no}}</ref>，旨在促進該疾病的研究、推廣，及病友支持<ref>{{Cite journal|last1=Fajgenbaum|first1=David C.|last2=Ruth|first2=Jason R.|last3=Kelleher|first3=Dermot|last4=Rubenstein|first4=Arthur H.|date=April 2016|title=The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease research|journal=[[柳葉刀_(雜誌)|The Lancet Haematology]] |volume=3|issue=4|pages=e150–152|doi=10.1016/S2352-3026(16)00007-7|issn=2352-3026|pmid=27063967}}</ref>。

== 參考文獻 ==
{{Reflist|2}}

== 延伸閱讀 ==
* {{Cite book |last=Fajgenbaum |first=David |year=2019 |title=Chasing My Cure: A Doctor's Race to Turn Hope into Action; a Memoir |url=https://books.google.com/books?id=OK1_DwAAQBAJ |location=New York |publisher=Ballantine Books |isbn=9781524799618 |oclc=1144129598 |access-date=2021-02-03 |archive-date=2021-05-17 |archive-url=https://web.archive.org/web/20210517153258/https://books.google.com/books?id=OK1_DwAAQBAJ |dead-url=no }} Book by the founder of the Castleman Disease Collaborative Network.

{{Medical resources
|  DiseasesDB      = 2165 
|  ICD10           = {{ICD10|D47.4}}
|  ICD9            = {{ICD9|785.6}} 
|  ICDO            = 
|  OMIM            = 
|  MedlinePlus     = 
|  eMedicineSubj   = 
|  eMedicineTopic  = 
|  MeshID          = D005871
}}

[[Category:免疫系统疾病|Category:免疫系统疾病]]